Inicio>>Signaling Pathways>> Endocrinology and Hormones>> Androgen Receptor>>SK33

SK33

Catalog No.GC64600

SK33, un anÁlogo de enobosarm trifluorometilado, es un antiandrÓgeno potente y selectivo de tejidos. SK33 reduce la actividad transcripcional del receptor de andrÓgenos (AR).

Products are for research use only. Not for human use. We do not sell to patients.

SK33 Chemical Structure

Cas No.: 1928724-23-5

Tamaño Precio Disponibilidad Cantidad
5 mg
288,00 $
Disponible
10 mg
441,00 $
Disponible
50 mg
1.215,00 $
Disponible

Tel:(909) 407-4943 Email: sales@glpbio.com

Reseñas de cliente

Based on customer reviews.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents

SK33, a trifluoromethylated enobosarm analog, is a potent, and tissue selective anti-androgen. SK33reduces androgen receptor (AR) transcriptional activity[1].

In LNCaPAR+ cells, SK33, demonstrates a significantly potent activity with IC50=0.2 μM. SK33 decreases cells entering S-phase in LNCaP cells. Treatment of LNCaP/BicR cells with increasing concentrations of SK33 for 96 hours results in a dose-dependent response and an inhibition of cell growth, with IC50 of approximately 5 μM for SK33[1].

SK33 (50 mg/kg; s.c.; 24 hours) inhibits AR transcriptional activity[1].

[1]. Dart DA, et al. Novel Trifluoromethylated Enobosarm Analogues with Potent Antiandrogenic Activity In Vitro and Tissue Selectivity In Vivo.Mol Cancer Ther. 2018 Sep;17(9):1846-1858.

Reseñas

Review for SK33

Average Rating: 5 ★★★★★ (Based on Reviews and 30 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for SK33

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.